Navigation Links
Super Bug Turns Super Killer

For a while, road accidents were the biggest killers. Now it appears that the ravage caused by the super bug Clostridium difficile, is equivalent// to the fatalities caused by road accidents.

Dr John Starr, reader in geriatric medicine at the University of Edinburgh, has provided statistics which demonstrates the increase in cases of C difficile, up by 5.5 per cent annually; in contrast, MRSA cases had dropped by 4.3 per cent. Nearly 50,000 patients above the age of 65 suffered C difficile infection in hospitals in England in 2006 and 7000 patients suffered MRSA.

A safety measure would be to ensure that patients who are to undergo routine surgeries be checked out for the presence of the bug. This measure will help curb the spread of infections.

Dr John Starr said, "With more than 2,200 deaths attributed to C difficile in death certificates in England and Wales, the mortality rate is fast approaching that for road traffic accidents and is now around half that for suicide. Control of C difficile is difficult because, unlike MRSA, alcohol hand scrubs are ineffective and its spores are resistant to routine hospital cleaning."

Therefore, it is imperative that patients be screened for the presence of the bacterium, prior to hospital admission. The bacterium in question called Clostridium difficile resides in the gut and makes its victim sick with diarrhea, that’s why the sobriquet “hospital diarrhea”.
SV
'"/>




Page: 1

Related medicine news :

1. Top Ten Super Food Items That Can Help In Avoiding Cancer
2. Top Ten Super Food Items That Can Help In Avoiding Cancer
3. Super Bugs Contaminate UK Chickens
4. Atypical Antibiotics For Super Bugs
5. Supercomputer Grid Enlists PCs To Combat AIDS
6. Amitabh Bachchan - India’s Superstar Undergoes Surgery
7. “Super Broccoli” Could Confer Better Cancer Protectin
8. Newer Generation Sleeping Pills Lack Superior Performance
9. The MRSA Superbug May Yet Be Overcome
10. Superbug Claims More Lives In Scotland
11. Little Clinic LLC Plans Super Medical Clinics in Publix Super Markets
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... Aliso Viejo, California (PRWEB) , ... December 04, ... ... self-animating lower third presets that have new attractive animation styles with unique displacement ... Pro3rd Displace features 30 pre-animated lower third designs. Choose from a variety of ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: